| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |